"10.1371_journal.pone.0137874","plos one","2015-09-14T00:00:00Z","Rajan P Adhikari; Thomas Kort; Sergey Shulenin; Tulasikumari Kanipakala; Nader Ganjbaksh; Mary-Claire Roghmann; Frederick W Holtsberg; M Javad Aman","Integrated Biotherapeutics Inc., Gaithersburg, Maryland, United States of America; Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America; VA Maryland Health Care System, Baltimore, Maryland, United States of America","Conceived and designed the experiments: RPA MJA. Performed the experiments: RPA T. Kort SS T. Kanipakala NG. Analyzed the data: RPA MJA. Contributed reagents/materials/analysis tools: MCR FWH. Wrote the paper: RPA MJA MCR FWH.","The authors have the following interests. This study was partly funded by Integrated BioTherapeutics, Inc. (IBT) internal R&D research fund. Rajan P. Adhikari, Thomas Kort, Sergey Shulenin, Frederick W. Holtsberg and M. Javad Aman are employees of Integrated Biotherapeutics Inc., a company that is developing vaccines for S. aureus. M. Javad Aman is a shareholder of the company and RPA, SS, and FWH own stock options in the company. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","09","Rajan P Adhikari","RPA",8,TRUE,2,2,2,4,TRUE,TRUE,TRUE,2,"3;5",TRUE
